H.R. 7180: Countering Captagon and Narcotics Post-Assad Act
The bill titled "Countering Captagon and Narcotics Post-Assad Act" proposes amendments to the National Defense Authorization Act to address narcotics production and trafficking in the Middle East. The key aspects of the bill are as follows:
Modification of Interagency Strategy
The bill aims to revise the existing interagency strategy that focuses on disrupting and dismantling narcotics production and trafficking networks in the Middle East. Key points include:
- The recognition that the production and trafficking of Captagon (a type of amphetamine), methamphetamine, and other stimulants have shifted following the fall of the Assad regime in Syria. This shift poses a significant threat to the stability of the region and U.S. interests.
- It identifies the need for urgent military and law enforcement actions to disrupt these narcotics networks and enhance border security.
- The bill emphasizes that Captagon contributes to instability in Syria and the broader Middle East.
Unclassified Written Strategy Requirement
The bill specifies that the strategy to tackle these issues must be unclassified and should include:
- An assessment of the evolving patterns of drug production and trafficking, particularly focusing on Captagon, methamphetamine, and similar stimulants.
- Identification of countries that are significant recipients or transit points for drugs in the region.
- An evaluation of these countries' capabilities to combat drug smuggling and trafficking.
- An analysis of current U.S. assistance programs that aim to build the capacity of these countries to fight narcotics.
- Insights on international cooperation aimed at disrupting narcotics infrastructure in the Middle East.
- Recommendations for actions to further dismantle drug production and trafficking networks, specifically those associated with the former Assad regime, Hezbollah, and Iranian proxies.
Objective of the Legislation
The overarching goal of the legislation is to enhance the U.S. government's ability to respond to and mitigate the challenges posed by narcotics trafficking in the Middle East, which has implications for regional security and U.S. foreign policy.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
3 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Jan. 21, 2026 | Introduced in House |
| Jan. 21, 2026 | Referred to the House Committee on Foreign Affairs. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.